Journal of Pharmacology and Experimental Therapeutics p. 359 - 367 (2017)
Update date:2022-08-17
Topics:
Harbeson, Scott L.
Morgan, Adam J.
Liu, Julie F.
Aslanian, Ara M.
Nguyen, Sophia
Bridson, Gary W.
Brummel, Christopher L.
Wu, Lijun
Tung, Roger D.
Pilja, Lana
Braman, Virginia
Uttamsingh, Vinita
Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals). Each therapy targets specific patient population
View MoreQuzhou Ruiyuan chemical Co., Ltd
Contact:+86-570-3039321/3039361/3039308
Address:18# Huayang Road,Quzhou High-tech Industrial Park, Zhejiang China.
Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
website:http://www.dawnraypharma.com/
Contact:+86-571-85335020
Address:1018 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
Chengdu Sino-Strong Pharmaceutical Co.,Ltd.
website:http://www.sino-strong.com.cn
Contact:+86-28-82666753
Address:459 West haike road,Cross-straits technological industry park, Wenjiang district,Chengdu, P.R.China
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Doi:10.1016/S0300-483X(02)00144-0
(2002)Doi:10.1016/S0040-4039(01)02207-9
(2002)Doi:10.1002/jrs.5381
(2018)Doi:10.1088/0953-8984/8/31/005
(1996)Doi:10.1016/0031-9422(90)89080-S
(1990)Doi:10.1002/anie.200601272
(2006)